good manufacturing practice by Anna Lundén AB ... - Textalk · 3. Annexes - Content. A...
Transcript of good manufacturing practice by Anna Lundén AB ... - Textalk · 3. Annexes - Content. A...
THE GMP HANDBOOKgood manufacturing practice
quality systems for the pharmaceutical industry
by Anna Lundén
ANNEXES Key2Compliance AB
© Key2C
ompli
ance
AB
3
Annexes - Content
A Requirements for procedures and records in 4 each respective GMP The symbols at the margins in the chapters of the handbook refer to the specific minimum requirement from the three differentGMP texts. These requirements are shown here with referrals to their respective paragraph in the separate GMPs.
B Referral to the requirements for verification of a 17 second individual (or equivalent systems) In the different GMP texts there are specific referrals to different forms of verifications or double checks of a second individual that is presented in this annex.
C Reference matrix ISO 9001 and GMP-texts 18In this matrix, the starting point is ISO 9001 and for each section there are references to corresponding requirements in the different GMPs. This matrix can be used as a supporting tool when a comprehensive quality system shall be designed with the ISO principles as a basis.
Annexes - Content
© Key2C
ompli
ance
AB
4
The GMP Handbook – quality systems for the pharmaceutical industry – Annexes
Req
uire
men
tsP
roce
dure
sR
ecor
dsD
escr
ipti
onId
enti
ficat
ion
Man
ager
ial/i
ndiv
idua
l res
pons
ibili
ties
1.04
, 1.0
5, 1
.07
Cha
p 2
Prin
cipl
e2.
03
Proc
essi
ng/p
acka
ging
pro
cedu
res
1.04
, 4.1
7, 4
.18
Rel
ease
pro
cedu
re a
nd Q
P ce
rtifi
catio
n1.
04, 4
.27
1.04
, 1.0
9, 2
.06
Self
-Ins
pect
ion
1.01
, 4.2
9, 9
.01
4.29
, 9.0
3
Qua
lity
Man
ual
1.07
Sam
plin
g, in
spec
tion
and
test
ing
of s
tart
ing
mat
eria
ls, i
nter
med
iate
, bul
k, a
nd fi
nish
ed p
rodu
ct1.
09, 4
.22,
4.2
5,
4.26
, 6.
07, 6
.11,
6.
12, 6
.15,
6.1
8
1.09
, 4.2
2, 4
.26,
5.
38, 6
.07,
6.1
1,
6.16
, 6.1
7, 6
.18
6.13
Env
iron
men
tal/m
edia
mon
itori
ng1.
9, 4
.29
3.19
, 4.2
9, 5
.43,
6.
07
Prod
uct Q
ualit
y R
evie
w1.
10 (
acco
rdin
g to
4.
29)
1.10
, 4.2
9
Ong
oing
rev
iew
of
corr
ectiv
e an
d pr
even
tive
actio
ns1.
04, 1
.11
1.04
, 1.1
1
Ris
k m
anag
emen
t (pr
oced
ure
not m
entio
ned
but m
ay b
e re
ques
ted)
1.12
1.12
Org
anis
atio
n ch
art
2.02
Eva
luat
ion
of p
rodu
ctio
n re
cord
s of
Pro
duct
ion
depa
rtm
ent
2.07
Tra
inin
g2.
11, 4
.29
2.11
, 4.2
9
An
nex
A.
Req
uir
emen
ts fo
r p
roce
du
res
and
rec
ord
s in
eac
h r
esp
ecti
ve G
MP
The
sym
bols
at t
he m
argi
ns in
the
chap
ters
ref
er to
the
spec
ific
min
imum
req
uire
men
t fro
m th
e th
ree
diff
eren
t GM
P te
xts.
The
se r
equi
rem
ents
are
sho
wn
here
with
ref
erra
ls to
thei
r re
spec
tive
para
grap
h in
the
sepa
rate
GM
Ps.
EU
GM
P G
uid
e P
art
I
© Key2C
ompli
ance
AB
5
Annex A© 2016 Key2Compliance AB
Req
uire
men
tsP
roce
dure
sR
ecor
dsD
escr
ipti
onId
enti
ficat
ion
Pers
onne
l hyg
iene
, hea
lth, a
nd c
loth
ing
2.15
, 2.1
6, 4
.29
4.29
Info
rmat
ion
abou
t con
sulta
nts
2.23
Prem
ises
- c
lean
ing,
dis
infe
ctio
n an
d id
entifi
catio
n3.
02, 4
.29,
5.2
14.
29, 5
.21
3.21
, 5.1
2, 5
.13
Equ
ipm
ent -
use
, cle
anin
g an
d id
entifi
catio
n3.
36, 4
.29,
4.3
0,
5.21
4.29
, 4.3
1, 5
.21
3.42
, 3.4
4, 5
.12,
5.
13
Cal
ibra
tion,
mai
nten
ance
, and
che
ckin
g 3.
41, 4
.29,
6.0
73.
41, 4
.29,
4.3
1,
6.07
Sani
tisin
g of
wat
er s
yste
ms
3.43
”Site
Mas
ter
file”
C
hap
4 Pr
inci
ple
Com
pute
rize
d sy
stem
s4.
01
Alte
ratio
ns in
doc
umen
ts4.
09
Just
ifica
tion
for
retir
emen
t of
reco
rds
4.12
Spec
ifica
tions
for
sta
rtin
g an
d pa
ckag
ing
mat
eria
ls
4.13
, 4.1
4, 6
.07
Spec
ifica
tions
for
fini
shed
pro
duct
s4.
13, 4
.16,
6.0
7
Spec
ifica
tions
for
inte
rmed
iate
and
bul
k pr
oduc
ts
4.15
, 6.0
7
Pack
agin
g in
stru
ctio
ns4.
19
Bat
ch p
roce
ssin
g re
cord
s4.
201.
08, 4
.20
Bat
ch p
acka
ging
rec
ords
4.21
4.21
Inte
rnal
labe
ling
4.24
Dis
trib
utio
n re
cord
s1.
08, 4
.28,
8.2
3
EU
GM
P G
uid
e P
art
I (co
nt.
)
© Key2C
ompli
ance
AB
8
The GMP Handbook – quality systems for the pharmaceutical industry – Annexes
Req
uire
men
tsP
roce
dure
sR
ecor
dsD
escr
ipti
onId
enti
ficat
ion
Rat
iona
l for
poi
nt o
f be
ginn
ing
1.2
Syst
em f
or q
ualit
y m
anag
emen
t2.
11
Pers
ons
auth
oris
ed to
rel
ease
2.14
Not
ifica
tion
to m
anag
emen
t2.
18
Ris
k m
anag
emen
t (pr
oced
ure
not m
entio
ned
but m
ay b
e re
ques
ted)
2.21
2.21
Res
pons
ibili
ties
of q
ualit
y un
it2.
32
Res
pons
ibili
ty f
or p
rodu
ctio
n2.
40
Inte
rnal
aud
its/s
elf
insp
ectio
n2.
502.
51
Prod
uct q
ualit
y re
view
2.60
, 2.6
1
Pers
onne
l res
pons
ibili
ties
3.11
Tra
inin
g3.
12
Rec
ords
on
cons
ulta
nts
3.31
Util
ity s
yste
ms
4.20
Wat
er q
ualit
y sp
ecifi
catio
ns4.
32
Val
idat
ion
and
qual
ifica
tion
4.33
, 4.4
1, 5
.40,
5.
41, 8
.45,
12.
10,
12.2
0, 1
2.30
, 12
.80,
18.
51
4.33
, 4.4
1, 5
.40,
5.
41, 5
.42,
8.4
5,
12.2
2, 1
2.23
, 12
.30,
12.
80,
12.8
3, 1
8.51
Inac
tivat
ion
and
clea
ning
4.41
Prev
entio
n of
cro
ss-c
onta
min
atio
n4.
42
EU
GM
P G
uid
e P
art
II
© Key2C
ompli
ance
AB
9
Annex A© 2016 Key2Compliance AB
EU
GM
P G
uid
e P
art
II (c
on
t.)
Req
uire
men
tsP
roce
dure
sR
ecor
dsD
escr
ipti
onId
enti
ficat
ion
Sew
age
and
refu
se4.
60
Sani
tatio
n an
d cl
eani
ng o
f bu
ildin
gs a
nd f
acili
ties
4.71
Use
of
rode
ntic
ides
etc
.4.
72
Dra
win
gs f
or e
quip
men
t and
inst
alla
tions
5.16
4.23
, 7.2
3
Equ
ipm
ent m
aint
enan
ce5.
206.
20, 6
.21
Cle
anin
g an
d re
leas
e of
equ
ipm
ent
5.21
, 5.2
5, 1
9.30
6.20
, 6.2
15.
26, 8
.16
Cal
ibra
tion
of e
quip
men
t5.
30, 1
9.30
5.32
, 6.6
15.
33
Cha
nges
to d
ata
5.43
Ope
ratio
n an
d m
aint
enan
ce o
f co
mpu
teri
zed
syst
ems
5.44
5.46
, 5.4
8
Cha
nges
to c
ompu
teri
zed
syst
ems
5.47
5.47
Doc
umen
t con
trol
6.10
2.15
Ret
entio
n of
doc
umen
ts6.
12
Spec
ifica
tions
and
acc
epta
nce
crite
ria
6.17
, 7.1
2, 9
.11,
11
.13
6.30
, 7.1
3
Equ
ipm
ent c
lean
ing
and
use
reco
rd6.
20
Mas
ter
prod
uctio
n re
cord
s6.
40, 6
.41
Han
dlin
g, s
tora
ge, t
est a
nd u
se o
f m
ater
ial
6.41
, 7.1
06.
307.
23, 7
.24
Bat
ch p
rodu
ctio
n re
cord
6.50
6.50
, 6.5
26.
51
Doc
umen
tatio
n an
d in
vest
igat
ion
arou
nd d
evia
tions
an
d fa
ilure
s6.
53, 1
1.15
2.16
, 5.4
6, 8
.15,
8.
20
Bat
ch a
nd c
ontr
ol r
ecor
d re
view
6.70
6.30
, 6.6
0
© Key2C
ompli
ance
AB
12
The GMP Handbook – quality systems for the pharmaceutical industry – Annexes
Req
uire
men
tsPr
oced
ures
Rec
ords
Identifi
cation
Res
pons
ibili
ties
of Q
CU
211.
22(d
)
Con
sulta
nts
211.
34
Cle
anin
g an
d sa
nita
tion
of b
uild
ings
and
fac
ilitie
s21
1.56
(b)
Use
of
rede
ntic
ides
etc
211.
56(c
)
Cle
anin
g, s
anita
tion,
mai
nten
ance
and
insp
ectio
n of
eq
uipm
ent
211.
67(b
)21
1.67
(c )
, 211
.182
Cal
ibra
tion
of e
quip
men
t21
1.68
(a),
211
.160
(b)
(4)
211.
68(a
), 2
11.1
82,
211.
194(
d)
Dat
a ba
ck-u
p21
1.68
(b)
Com
pute
r pr
ogra
m v
alid
atio
n21
1.68
(b)
211.
68(b
)
Rec
eipt
, ide
ntifi
catio
n, s
ampl
ing
etc
of c
ompo
nent
s,
cont
aine
rs a
nd c
losu
res
211.
80(a
), 2
11.8
4(c)
, 21
1.16
0(a)
211.
184(
a)&
(b)
211.
80(d
), 2
11.8
4(c
),
211.
89
Com
pone
nt s
peci
ficat
ions
211.
84(d
)(2)
211.
184(
b)
Con
tain
ers
and
clos
ures
spe
cific
atio
ns21
1.84
(d)(
3) &
(5)
, 21
1.94
(d)
Val
idat
ion
of s
uppl
iers
’ te
st r
esul
ts21
1.84
(d)
211.
84(d
)
Val
idat
ion
of d
epyr
ogen
atio
n pr
oces
ses
211.
9421
1.94
Prod
uctio
n an
d pr
oces
s pr
oced
ures
211.
100(
a)21
1.10
0(b)
Dev
iatio
n fr
om w
ritte
n pr
oced
ures
211.
100(
b)
Cha
rge-
in o
f co
mpo
nent
s21
1.10
121
1.10
1(b)
The
oret
ical
and
act
ual y
ield
211.
103
211.
103
US
21
CF
R 2
11 © Key2C
ompli
ance
AB
13
Annex A© 2016 Key2Compliance AB
US
21
CF
R 2
11 (
con
t.)
Req
uire
men
tsPr
oced
ures
Rec
ords
Identifi
cation
Equ
ipm
ent i
dent
ifica
tion
211.
105
In-p
roce
ss c
ontr
ols
and
valid
atio
n21
1.11
0(a)
211.
110(
a)
In-p
roce
ss s
peci
ficat
ions
211
.110
(b)
Spec
ifica
tions
, sta
ndar
ds, s
ampl
ing
plan
s an
d te
stin
g pr
oced
ures
211.
110(
c ),
21
1.16
0(a)
&(b
),
211.
165,
211
.186
(b)
211.
160(
a), 2
11.1
94(a
)21
1.16
0(b)
Rej
ecte
d in
-pro
cess
mat
eria
l21
1.11
0(d)
Tim
e lim
its21
1.11
121
1.11
1
Con
tam
inat
ion
cont
rol
211.
113(
a)
Con
tam
inat
ion
cont
rol,
ster
ile p
rodu
cts
211.
113(
b)
Val
idat
ion
of a
sept
ic a
nd s
teri
lizat
ion
proc
esse
s21
1.11
3(b)
211.
113(
b)
Rep
roce
ssin
g21
1.11
5(a)
Exa
min
atio
n of
pac
kagi
ng a
nd la
belin
g m
ater
ials
211.
122(
a)21
1.12
2(c
), 2
11.1
84
(b),
211
.184
(d)
211.
122(
d)
Rec
onci
liatio
n of
labe
ling
211.
125(
c)12
2.12
5(e
)
Issu
ance
of
labe
ling
211.
125(
f)
Pack
agin
g an
d la
belin
g21
1.13
021
1.13
0(d)
&(e
),
211.
184(
d)21
1.13
0(b)
&(c
)
Dru
g pr
oduc
t ins
pect
ion
211.
134(
c )
Exp
irat
ion
datin
g21
1.13
7(c
)&(d
)
War
ehou
sing
211.
142
© Key2C
ompli
ance
AB
17
Annex B© 2016 Key2Compliance AB
Annex B. Referral to the requirements for verification of a second individual (or equivalent systems)
In the different GMP texts there are specific referrals to different forms of verifications or double checks of a second individual that is presented in this annex.
21CFR210/211 211.67(b)(6) Inspection of equipment211.101(c) Weighing of drug components211.101(d) Adding of drug components211.103 Calculation of yield211.122(g)(3) Use of cut labeling211.182 Equipment cleaning and maintenance211.188(b)(11) Significant steps
EU Guide to GMP Part I4.18(c) Manufacturing equipment checks4.19(f) Packing equipment checks4.20(c)&4.21(c) Significant steps, e.g. weighing5.38 Dispensed material 6.16 Test result calculations6.17(g) Laboratory test result verification
EU Guide to GMP Part II 5.21 Inspection of equipment5.45 Entering critical data manually in computerized systems6.52 Critical steps in production6.60 Laboratory records8.12 Critical weighing, measuring, or subdividing operations8.13 Critical activities9.44 Inspection of packaging and labelling facilities
© Key2C
ompli
ance
AB
18
The GMP Handbook – quality systems for the pharmaceutical industry – Annexes
Annex C. Reference matrix ISO 9001 and GMP texts
In this annex we have used the structure from ISO 9001:2015 as the base and correlated it to the corresponding requirements in the GMP’s. Note that the requirements of the ISO- standard does not have the same degree of detail and not specifically require procedures and
ISO 9001 Requirement description EU GMP PART I 21CFR210/211 EU GMP PART II
4.4.1;7.5.1
Quality management system established Ch. 1, Principle;1.1;1.7
na 2.11;2.19;17.30
4.4.1 a, b Determining processes, sequence and their interaction 1.8(i) na 2.12
4.4.1 c,d,e,f Criteria, methods and resources for control of processes 1.4(i)&(iv) na 2.124.4.1 f;6.1
Risk management Ch. 1, Principle;1.3;1.12-135.20-21;Ch. 8, Principle;
na 2.20-21
4.4.1 g Monitor, measure and analyze processes and act on the results. Ch. 1, Principle;1.4(vi);1.4(viii)&(ix);1.10;2.8-9;Ch. 4, Principle;6.2;6.9;6.26-36;7.7
211.100;211.180(e);211.192
2.60;6.71;11.15;15.12
na Quality manual 1.7;4.32
na na
4.4.2 Documented procedures and specifications Ch. 4, Principle 211.22(c)&(d);211.100(a);211.160(a)
2.12
4.4.2 Records Ch. 4, Principle;4.8
211.180 2.15;6.14
5.1.1 f Top management shall communicate the importance of quality 1.5 na 2.115.2.1 ;5.1.1 b;6.2.1
Quality policy and quality objectives established by management Ch. 1, Principle; 2.4
na 2.19
5.2.2 Quality policy communicated and understood within the organization Ch. 1, Principle; 1.5
na 2.10-11
© Key2C
ompli
ance
AB
19
Annex C© 2016 Key2Compliance AB
records the same way as in the GMP’s, but contains general principles for a complete quality management system. Requirements in the ISO standard where there is no equiva-lent in the GMP’s have been omitted (eg requirements related to design and development).
ISO 9001 Requirement description EU GMP PART I 21CFR210/211 EU GMP PART II
4.4.1;7.5.1
Quality management system established Ch. 1, Principle; 1.1; 1.7
na 2.11;2.19;17.30
4.4.1 a, b Determining processes, sequence and their interaction 1.8(i) na 2.12
4.4.1 c,d,e,f Criteria, methods and resources for control of processes 1.4(i)&(iv) na 2.124.4.1 f;6.1
Risk management Ch. 1, Principle; 1.3; 1.12-135.20-21;Ch. 8, Principle;
na 2.20-21
4.4.1 g Monitor, measure and analyze processes and act on the results. Ch. 1, Principle; 1.4(vi); 1.4(viii)&(ix); 1.10; 2.8-9; Ch. 4, Principle; 6.2; 6.9; 6.26-36; 7.7
211.100; 211.180(e); 211.192
2.60;6.71;11.15;15.12
na Quality manual 1.7; 4.32
na na
4.4.2 Documented procedures and specifications Ch. 4, Principle 211.22(c)&(d); 211.100(a); 211.160(a)
2.12
4.4.2 Records Ch. 4, Principle; 4.8
211.180 2.15;6.14
5.1.1 f Top management shall communicate the importance of quality 1.5 na 2.115.2.1 ;5.1.1 b;6.2.1
Quality policy and quality objectives established by management Ch. 1, Principle; 2.4
na 2.19
5.2.2 Quality policy communicated and understood within the organization Ch. 1, Principle; 1.5
na 2.10-11
© Key2C
ompli
ance
AB